查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1938350

脊髓刺激設備市場－全球產業規模、佔有率、趨勢、機會及預測（依產品類型、應用、最終用戶、地區及競爭格局分類），2021-2031年

Spinal Cord Stimulation Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By Application, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球脊髓刺激設備市場預計將從 2025 年的 39.8 億美元成長到 2031 年的 68.8 億美元，複合年成長率達到 9.55%。

這些植入式神經調控系統透過向脊髓傳遞電脈衝來阻斷疼痛訊號，使其成為治療方法慢性神經病變疼痛的重要手段。市場成長的主要促進因素包括全球慢性疼痛綜合症發病率的上升、人口老化以及臨床治療轉向非鴉片類鎮痛藥物。美國國家疼痛基金會近期發布的統計數據凸顯了這一巨大需求：預計到2024年，美國將有5,160萬成年人患有慢性疼痛，顯示對先進治療方案的需求十分旺盛。

市場概覽
預測期 2027-2031
市場規模：2025年 39.8億美元
市場規模：2031年 68.8億美元
複合年成長率：2026-2031年 9.55%
成長最快的細分市場 可充電的
最大的市場 北美洲

然而，由於監管機構對這些設備的長期安全性和有效性審查日益嚴格，市場擴張面臨巨大的阻力。監管機構正在對上市前臨床證據和上市後監測實施更嚴格的標準，以最大限度地減少導線移位和感染等併發症。這些嚴格的監管措施，加上植入手術的高成本以及不同醫療體系中複雜的報銷機制，造成了財務和程序上的障礙，限制了患者更廣泛地獲得和使用該技術。

市場促進因素

推動全球脊髓刺激設備市場發展的關鍵因素是慢性疼痛疾病的日益增加以及非鴉片類藥物治療策略的強勁成長。隨著醫療基礎設施逐步改善以應對鴉片類藥物危機，植入式神經調控療法正逐漸成為保守治療無效患者的首選長期解決方案。近期流行病學數據也印證了這項需求的迫切性。美國疾病管制與預防中心 (CDC) 在其 2024 年 11 月發布的《發病率和死亡率週報》中指出，2023 年美國成年人中慢性疼痛的盛行率為 24.3%，這表明介入治療擁有龐大的目標族群。

此外，新一代脊髓刺激（SCS）技術的進步正在推動市場發展，這些技術提高了治療效果和患者依從性。技術創新已從標準的連續刺激發展到先進的封閉回路型系統，該系統能夠自動適應神經波動，從而改善臨床療效並降低消融率。這項技術進步也體現在主要產業領導者的財務表現。波士頓科學公司在2024年10月發布的「2024會計年度第三季財報」中指出，其神經調控收入成長了17%，這主要得益於其先進的設備組合。同樣，美敦力公司在2024年8月發布的「第一季財報」中也顯示，其神經科學產品組合的營收已增至23億美元，證實了這些神經刺激技術的強勁商業性潛力。

市場挑戰

全球脊髓刺激設備市場的成長受到複雜報銷體系和嚴格程序障礙的顯著限制，限制了患者獲得這些先進治療方法。保險公司和醫療系統日益實施嚴格的核准流程，並要求提供保守治療失敗的詳細記錄，方可批准核准。這些行政障礙導致治療交付嚴重延誤，常常迫使患者徹底放棄治療。最終形成瓶頸，由於支付方的限制，患者的高需求無法轉化為實際的設備植入。

美國醫學會 (AMA) 的數據凸顯了這些程序性挑戰的嚴重性：該協會報告稱，2024 年，93% 的醫生認為事先核准程序會顯著延誤患者必要的治療。這項統計數據顯示了市場面臨的障礙規模之大。當醫療服務提供者被迫進行耗費資源且結果不確定的核准流程時，提供這些專業服務的經濟可行性就會降低。這反過來又會阻礙脊髓刺激技術的廣泛應用，並削弱市場應對日益普遍的慢性疼痛的能力。

市場趨勢

塑造市場格局的關鍵趨勢是技術進步推動植入式脈衝產生器 (IPG) 和微型刺激器體積顯著縮小，創傷更小。這些緊湊型設備能夠縮小手術切口，提高患者舒適度，並增加植入位置的柔軟性，從而直接解決患者對植入部位疼痛和裝置可見度的擔憂。向微創解決方案的轉變得到了大量投資的支持。例如，Nalu Medical, Inc. 在 2024 年 3 月發布的題為「Nalu Medical, Inc. 完成 E 輪融資 8,500 萬美元」的新聞稿中披露，該公司已獲得 8,500 萬美元的股權資金籌措，用於加速其微型神經刺激系統的商業性擴張。

同時，無線連接和行動應用程式的普及正大力推動遠端患者監護的發展，使臨床醫生無需頻繁到診即可追蹤使用數據並調整設定。這種數位化整合提高了患者參與度，簡化了護理流程，尤其對居住在偏遠地區、需要持續治療監督的患者更是如此。這種互聯護理模式的正面影響在近期的市場表現中顯而易見。在2024年10月發布的《雅培公佈2024年第三季業績》中，雅培報告稱，其醫療設備部門的收入成長了11.7%，部分原因是其互聯神經調控產品線的成功應用，該產品線支持無縫遠端系統管理。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球脊髓刺激設備市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依產品類型（可充電式與不可充電式）
    • 依應用領域（腰椎手術後症候群、複雜性局部疼痛症候群、椎間盤退化性疾病、椎間盤手術失敗等）
    • 按最終使用者（醫院/診所、門診護理中心、其他）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美脊髓刺激設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

7. 歐洲脊髓刺激設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章 亞太地區脊髓刺激設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

9. 中東和非洲脊髓刺激設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美脊髓刺激設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球脊髓刺激設備市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Abbott Laboratories
  • Medtronic plc
  • Boston Scientific Corporation
  • Nevro Corporation
  • Stimwave LLC
  • Nuvectra Corporation
  • Biotronik SE & Co. KG
  • Mainstay Medical International plc
  • Nevro Inc.
  • Sapiens Spine LLC

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 7359

The Global Spinal Cord Stimulation Devices Market is projected to expand from USD 3.98 Billion in 2025 to USD 6.88 Billion by 2031, achieving a CAGR of 9.55%. These implantable neuromodulation systems function by transmitting electrical impulses to the spinal cord to intercept pain signals, serving as a vital treatment for chronic neuropathic pain. Market growth is largely propelled by the rising global incidence of chronic pain syndromes, an aging population, and a clinical shift towards non-opioid pain management. This substantial need is highlighted by recent statistics from the U.S. Pain Foundation, which reported in 2024 that 51.6 million adults in the United States live with chronic pain, emphasizing the critical demand for advanced therapeutic solutions.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 3.98 Billion
Market Size 2031USD 6.88 Billion
CAGR 2026-20319.55%
Fastest Growing SegmentRechargeable
Largest MarketNorth America

However, market expansion faces significant headwinds due to heightened regulatory scrutiny concerning the long-term safety and efficacy of these devices. Regulatory bodies are imposing stricter standards for pre-market clinical evidence and post-market surveillance to minimize complications such as lead migration or infection. These rigorous oversight measures, combined with the high costs associated with implantation procedures and complex reimbursement frameworks across various healthcare systems, establish economic and procedural hurdles that restrict broader patient access and technology adoption.

Market Driver

The primary engines driving the Global Spinal Cord Stimulation Devices Market are the increasing frequency of chronic pain disorders and a resolute transition toward non-opioid management strategies. As healthcare infrastructure seeks to combat the opioid epidemic, implantable neuromodulation has emerged as a favored long-term solution for patients who have not found relief through conservative treatments. The urgency of this demand is reinforced by recent epidemiological data; the Centers for Disease Control and Prevention noted in their November 2024 'Morbidity and Mortality Weekly Report' that 24.3 percent of adults in the United States experienced chronic pain in 2023, representing a vast population eligible for interventional therapies.

Furthermore, the market is propelled by advancements in next-generation SCS technologies that improve therapeutic effectiveness and patient adherence. Innovation has evolved from standard tonic stimulation to sophisticated closed-loop systems that automatically adapt to neural variations, thereby enhancing clinical outcomes and decreasing explant rates. This technological progress is reflected in the financial results of major industry leaders; Boston Scientific reported in their 'Third Quarter 2024 Financial Results' in October 2024 that their Neuromodulation segment sales grew by 17 percent due to advanced device portfolios. Similarly, Medtronic's 'First Quarter Fiscal Year 2025 Financial Results' from August 2024 showed Neuroscience portfolio revenue rising to 2.3 billion U.S. dollars, confirming the strong commercial viability of these neurostimulation technologies.

Market Challenge

The growth of the Global Spinal Cord Stimulation Devices Market is severely constrained by complicated reimbursement frameworks and strict procedural barriers that limit patient access to these sophisticated therapies. Insurance providers and healthcare systems increasingly enforce rigorous prior authorization processes and demand extensive documentation of failed conservative treatments before granting coverage approval. These administrative obstacles cause substantial delays in the delivery of care, frequently leading patients to abandon the treatment process altogether, creating a bottleneck where high patient demand fails to translate into device implantations due to payer restrictions.

The severity of these procedural challenges is highlighted by data from the American Medical Association, which reported in 2024 that 93% of physicians found prior authorization processes to significantly delay necessary patient care. This statistical evidence illustrates the scale of the obstacles confronting the market. When healthcare providers are compelled to navigate resource-heavy approval procedures with uncertain results, the economic viability of providing these specialized services declines, thereby discouraging the widespread adoption of spinal cord stimulation technologies and hindering the market's capacity to address the growing prevalence of chronic pain.

Market Trends

A key trend shaping the market is the technological drive toward developing significantly smaller and less invasive implantable pulse generators (IPGs) and micro-stimulators. These compact devices allow for smaller surgical incisions, enhance patient comfort, and offer greater flexibility in placement, directly addressing patient concerns regarding implant site pain and device visibility. The shift toward minimally invasive solutions is supported by substantial investment; for instance, Nalu Medical, Inc. announced in a March 2024 press release titled 'Nalu Medical, Inc. Closes $85 Million Series E Round' that it raised 85 million U.S. dollars in equity financing explicitly to accelerate the commercial expansion of its miniaturized neurostimulation system.

Concurrently, the incorporation of wireless connectivity and mobile applications is fostering a strong movement toward remote patient monitoring, enabling clinicians to track usage data and adjust settings without requiring frequent in-clinic visits. This digital integration improves patient engagement and streamlines care, particularly for individuals in remote locations who need consistent therapeutic supervision. The positive impact of this connected care model is evident in recent market performance; Abbott reported in its 'Abbott Reports Third-Quarter 2024 Results' in October 2024 that its Medical Devices segment achieved an 11.7 percent increase in reported sales, driven in part by the successful adoption of its connected neuromodulation portfolio that supports seamless remote management.

Key Market Players

  • Abbott Laboratories
  • Medtronic plc
  • Boston Scientific Corporation
  • Nevro Corporation
  • Stimwave LLC
  • Nuvectra Corporation
  • Biotronik SE & Co. KG
  • Mainstay Medical International plc
  • Nevro Inc.
  • Sapiens Spine LLC

Report Scope

In this report, the Global Spinal Cord Stimulation Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Spinal Cord Stimulation Devices Market, By Product Type

  • Rechargeable v/s Non-Rechargeable

Spinal Cord Stimulation Devices Market, By Application

  • Failed Back Syndrome
  • Complex Regional Pain Syndrome
  • Degenerative Disk Disease
  • Unsuccessful Disk Surgery
  • Others

Spinal Cord Stimulation Devices Market, By End User

  • Hospitals & Clinics
  • Ambulatory Care Centers
  • Others

Spinal Cord Stimulation Devices Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Spinal Cord Stimulation Devices Market.

Available Customizations:

Global Spinal Cord Stimulation Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Spinal Cord Stimulation Devices Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type (Rechargeable v/s Non-Rechargeable)
    • 5.2.2. By Application (Failed Back Syndrome, Complex Regional Pain Syndrome, Degenerative Disk Disease, Unsuccessful Disk Surgery, Others)
    • 5.2.3. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Spinal Cord Stimulation Devices Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By Application
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Spinal Cord Stimulation Devices Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product Type
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Spinal Cord Stimulation Devices Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product Type
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Spinal Cord Stimulation Devices Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product Type
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End User

7. Europe Spinal Cord Stimulation Devices Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By Application
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Spinal Cord Stimulation Devices Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End User
    • 7.3.2. France Spinal Cord Stimulation Devices Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Spinal Cord Stimulation Devices Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Spinal Cord Stimulation Devices Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product Type
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Spinal Cord Stimulation Devices Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product Type
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End User

8. Asia Pacific Spinal Cord Stimulation Devices Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By Application
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Spinal Cord Stimulation Devices Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End User
    • 8.3.2. India Spinal Cord Stimulation Devices Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Spinal Cord Stimulation Devices Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Spinal Cord Stimulation Devices Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product Type
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Spinal Cord Stimulation Devices Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product Type
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End User

9. Middle East & Africa Spinal Cord Stimulation Devices Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By Application
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Spinal Cord Stimulation Devices Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End User
    • 9.3.2. UAE Spinal Cord Stimulation Devices Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End User
    • 9.3.3. South Africa Spinal Cord Stimulation Devices Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End User

10. South America Spinal Cord Stimulation Devices Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By Application
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Spinal Cord Stimulation Devices Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End User
    • 10.3.2. Colombia Spinal Cord Stimulation Devices Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End User
    • 10.3.3. Argentina Spinal Cord Stimulation Devices Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Spinal Cord Stimulation Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Abbott Laboratories
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Medtronic plc
  • 15.3. Boston Scientific Corporation
  • 15.4. Nevro Corporation
  • 15.5. Stimwave LLC
  • 15.6. Nuvectra Corporation
  • 15.7. Biotronik SE & Co. KG
  • 15.8. Mainstay Medical International plc
  • 15.9. Nevro Inc.
  • 15.10. Sapiens Spine LLC

16. Strategic Recommendations

17. About Us & Disclaimer